Following the recent BRAVE-AA trials Olumiant (baricitinib) has become the first USFDA approved systemic treatment (i.e. treats the entire body rather than a specific location) for Alopecia Areata. About the new Drug (Baricitinib) Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited.

Read More

The hair loss condition Alopecia Areata was thrown into the headlines this week when Chris Rock made an inappropriate joke about Jada Pinkett Smith’s shaved head at the Oscars. Jada was visibly upset following the comment. Jada has been open about her journey with Alopecia Areata over recent years and in 2021 explained that her

Read More

Contact Us